Refractory Coronary Stent Thrombosis in a Patient with Chronic Immune Thrombocytopenia on Eltrombopag

被引:0
|
作者
Chen, Tse-Wei [1 ]
Huang, Ting-Chun [1 ,2 ]
Huang, Chen-Wei [1 ]
Liu, Ping-Yen [1 ,2 ]
机构
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Cardiol, Dept Internal Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan
关键词
ITP;
D O I
10.6515/AC5.202109_37(5).20210518A
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:542 / 545
页数:4
相关论文
共 50 条
  • [1] Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag
    Satoh, Terumori
    Saotome, Masao
    Suwa, Kenichiro
    Ohtani, Hayato
    Nagata, Yasuyuki
    Ono, Takaaki
    Maekawa, Yuichiro
    CASE REPORTS IN CARDIOLOGY, 2019, 2019
  • [3] Spotlight on Eltrombopag in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
    Karly P. Garnock-Jones
    BioDrugs, 2011, 25 : 401 - 404
  • [4] Spotlight on Eltrombopag in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
    Garnock-Jones, Karly P.
    BIODRUGS, 2011, 25 (06) : 401 - 404
  • [5] Eltrombopag named patient programme for patients with chronic immune thrombocytopenia
    Scully, Maria
    Kaczmarski, Richard
    Myers, Bethan
    Collins, Rod
    Emohare, Osa
    Bolton-Maggs, Paula H. B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (02) : 259 - 260
  • [6] Eltrombopag for chronic immune thrombocytopenia Reply
    Cheng, Gregory
    Saleh, Mansoor N.
    Marcher, Claus
    Aivado, Manuel
    Brainsky, Andres
    Bussel, James B.
    LANCET, 2011, 377 (9781): : 1919 - 1920
  • [7] Eltrombopag for chronic immune thrombocytopenia reply
    Grainger, John D.
    LANCET, 2016, 387 (10016): : 336 - 337
  • [8] Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia
    Kim, Yeo-Kyeoung
    Chung, Sung-Hoon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Il-Kwon
    Kim, Nan-Young
    Yu, Li
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD, 2013, 122 (21)
  • [9] NOVEL PERSPECTIVES IN PATIENTS WITH REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA FOLLOWING ELTROMBOPAG TREATMENT
    Kaliou, M.
    Gavriilaki, E.
    Bousiou, Z.
    Papadimitriou, S.
    Papaioanou, G.
    Tsirou, K.
    Syrigou, A.
    Iskas, M.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2016, 101 : 832 - 832
  • [10] Alternative Dosing of Eltrombopag for the Treatment of Chronic, Steroid-Refractory Immune Thrombocytopenia
    Syed, Salman
    Stein, Hadassah
    Ganz, Marc
    Miller, Daniel
    Lachhar, Garry
    Sawhney, Harinder
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)